Forbion Growth Opportunities Fund III Cooperatief U.A., 10% Owner at Braveheart Bio, Inc. (BRVE), bought 3,600,000 shares at $18.00 ($64.8M) on 2026-08-07, disclosed to the SEC on 2026-08-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 1,680,000 | $30.2M | 46.7% |
| 2 | $18.00 | 1,920,000 | $34.6M | 53.3% |
| Total | $18.00 avg | 3,600,000 | $64.8M | 100% |